Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
27.71
+0.58 (2.14%)
At close: Feb 11, 2026, 4:00 PM EST
28.20
+0.49 (1.76%)
After-hours: Feb 11, 2026, 7:47 PM EST
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $1.62 billion as of February 11, 2026. Its market cap has decreased by -16.05% in one year.
Market Cap
1.62B
Enterprise Value
403.19M
1-Year Change
-16.05%
Ranking
Category
Stock Price
$27.71
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $1.62B, an increase of 75.83%. That is a compound annual growth rate of 4.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.58B | -0.33% |
| Dec 31, 2025 | 1.59B | -15.30% |
| Dec 31, 2024 | 1.87B | 50.56% |
| Dec 29, 2023 | 1.24B | -19.33% |
| Dec 30, 2022 | 1.54B | -13.57% |
| Dec 31, 2021 | 1.79B | -40.52% |
| Dec 31, 2020 | 3.00B | 6.73% |
| Dec 31, 2019 | 2.81B | 4.81% |
| Dec 31, 2018 | 2.68B | -3.76% |
| Dec 29, 2017 | 2.79B | 58.97% |
| Dec 30, 2016 | 1.75B | -28.25% |
| Dec 31, 2015 | 2.44B | -37.12% |
| Dec 31, 2014 | 3.89B | 420.55% |
| Dec 31, 2013 | 746.50M | -18.77% |
| Jul 24, 2013 | 919.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.67B |
| Enliven Therapeutics | 1.66B |
| Nurix Therapeutics | 1.66B |
| Corvus Pharmaceuticals | 1.65B |
| Oculis Holding AG | 1.65B |
| MBX Biosciences | 1.65B |
| Veradermics | 1.64B |
| Celldex Therapeutics | 1.64B |